Akathisia: Difference between revisions
| (One intermediate revision by the same user not shown) | |||
| Line 30: | Line 30: | ||
==References== | ==References== | ||
<references/> | <references/> | ||
[[Category:Neurology]] | |||
Latest revision as of 14:29, 25 November 2021
Background
- Defined as restlessness, inability to sit still, distressing disquiet
- Commonly caused as a medication side effect (e.g. prochlorperazine, droperidol)
Clinical Features
- Restlessness, inability to sit still, distressing disquiet
Differential Diagnosis
Evaluation
Workup
- Generally not required
Diagnosis
- Clinical diagnosis
Management
- Diphenhydramine (50mg PO/IM/IV) OR benztropine (1-2mg IV)[1][2]
Disposition
See Also
External Links
References
- ↑ Pringsheim T, Gardner D, Addington D, et al. The Assessment and Treatment of Antipsychotic-Induced Akathisia. Can J Psychiatry. 2018;63(11):719-729. doi:10.1177/0706743718760288
- ↑ Rice, J. CoreEM.net - Akathisia. https://coreem.net/core/akathisia/ Accessed: Oct 4, 2021.